This resource is a step-by-step EMR guide for appropriate US population health decision makers or similar entities and their health systems to identify the subset of patients who may have clinical characteristics of advanced polycythemia vera (PV).
View Resource
Understanding both the benefits to be had from offering BsAb therapy to its community and the scope of this undertaking, Vanderbilt-Ingram Cancer Center took a novel approach with its APP-led BsAb step-up dosing clinic, which won the program a 2026 ACCC Innovator Award.
